Bibliometric Analysis of Global Pediatric Research on Cow's Milk Protein Allergy.

IF 3 3区医学 Q2 ALLERGY Journal of Asthma and Allergy Pub Date : 2025-01-23 eCollection Date: 2025-01-01 DOI:10.2147/JAA.S487698

Xiaolan Lin, Yifan Chen, Weidong Lin

{"title":"Bibliometric Analysis of Global Pediatric Research on Cow's Milk Protein Allergy.","authors":"Xiaolan Lin, Yifan Chen, Weidong Lin","doi":"10.2147/JAA.S487698","DOIUrl":null,"url":null,"abstract":"Background: Cow's milk protein allergy (CMPA) is a prevalent food allergy in early childhood, significantly impacting the quality of life for affected children. Current palliative measures, such as specialized formula milk, offer temporary relief but are costly and fail to address the underlying issue. Thus, there is a critical need to better understand CMPA and explore new treatment options.Methods: This study employed bibliometric methods to analyze global pediatric CMPA research and identify future directions for the first time. Visual analyses were conducted using VOS Viewer and CiteSpace software.Results: A total of 2040 articles published between 2000 and 2023 showed increasing annual publications. In this field of research, the Icahn School of Medicine at Mount Sinai has made significant contributions, with the most influential articles published in the Journal of Allergy and Clinical Immunology. Current research emphasizes personalized therapy, probiotics, and gut microbiota in CMPA.Conclusion: Future research will focus on microbiota-related personalized treatments, promising effective clinical interventions.","PeriodicalId":15079,"journal":{"name":"Journal of Asthma and Allergy","volume":"18 ","pages":"85-100"},"PeriodicalIF":3.0000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11771186/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Asthma and Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JAA.S487698","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Cow's milk protein allergy (CMPA) is a prevalent food allergy in early childhood, significantly impacting the quality of life for affected children. Current palliative measures, such as specialized formula milk, offer temporary relief but are costly and fail to address the underlying issue. Thus, there is a critical need to better understand CMPA and explore new treatment options.

Methods: This study employed bibliometric methods to analyze global pediatric CMPA research and identify future directions for the first time. Visual analyses were conducted using VOS Viewer and CiteSpace software.

Results: A total of 2040 articles published between 2000 and 2023 showed increasing annual publications. In this field of research, the Icahn School of Medicine at Mount Sinai has made significant contributions, with the most influential articles published in the Journal of Allergy and Clinical Immunology. Current research emphasizes personalized therapy, probiotics, and gut microbiota in CMPA.

Conclusion: Future research will focus on microbiota-related personalized treatments, promising effective clinical interventions.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

全球儿童牛奶蛋白过敏研究的文献计量学分析。

背景：牛奶蛋白过敏（Cow's milk protein allergy， CMPA）是儿童早期常见的食物过敏，严重影响儿童的生活质量。目前的缓解措施，如专门配方奶粉，提供了暂时的缓解，但成本高昂，未能解决根本问题。因此，迫切需要更好地了解CMPA并探索新的治疗方案。方法：本研究首次采用文献计量学方法对全球儿童CMPA研究进行分析，并确定未来的研究方向。使用VOS Viewer和CiteSpace软件进行可视化分析。结果：2000 - 2023年共发表文章2040篇，年发表量呈逐年增加趋势。在这一研究领域，西奈山的伊坎医学院做出了重大贡献，最具影响力的文章发表在《过敏与临床免疫学杂志》上。目前的研究强调CMPA的个性化治疗、益生菌和肠道微生物群。结论：未来的研究将重点放在与微生物群相关的个性化治疗上，有望实现有效的临床干预。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Asthma and Allergy Medicine-Immunology and Allergy

CiteScore

5.30

自引率

6.20%

发文量

185

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physiology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies. Although the main focus of the journal will be to publish research and clinical results in humans, preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies.